Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMTX
AMTX logo

AMTX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Aemetis Inc (AMTX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.190
1 Day change
6.98%
52 Week Range
3.660
Analysis Updated At
2026/03/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Aemetis Inc (AMTX) is not a good buy for a beginner, long-term investor at this time. The stock shows weak financial performance, overbought technical indicators, and lacks positive catalysts or strong trading signals. Additionally, the stock is projected to decline further in the short term, making it unsuitable for immediate entry.

Technical Analysis

The MACD histogram is positive at 0.124 but contracting, indicating weakening momentum. RSI at 83.053 signals the stock is overbought. Moving averages are converging, suggesting indecision in price trends. The stock is trading close to its resistance level (R1: 3.226), with limited upside potential and a high chance of reversal. Short-term projections indicate a likely decline in price (-2.45% next day, -4.61% next week, -4.67% next month).

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
10

Positive Catalysts

  • NULL identified. No recent news or significant insider or hedge fund activity. No AI Stock Picker or SwingMax signals.

Neutral/Negative Catalysts

  • Weak financial performance in Q4 2025, with declining net income (-67.09% YoY), EPS (-75.00% YoY), and gross margin (-241.93% YoY). Overbought RSI and high probability of short-term price decline. Lack of recent congress trading data or influential figure activity.

Financial Performance

In Q4 2025, revenue increased by 14.16% YoY to $53.66M, but net income dropped significantly to -$5.33M (-67.09% YoY). EPS fell to -0.08 (-75.00% YoY), and gross margin declined sharply to 10.9% (-241.93% YoY), indicating poor profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available for evaluation.

Wall Street analysts forecast AMTX stock price to rise
1 Analyst Rating
Wall Street analysts forecast AMTX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.980
sliders
Low
20
Averages
20
High
20
Current: 2.980
sliders
Low
20
Averages
20
High
20
UBS
Manav Gupta
maintain
$3
AI Analysis
2025-06-30
Reason
UBS
Manav Gupta
Price Target
$3
AI Analysis
2025-06-30
maintain
Reason
UBS analyst Manav Gupta raised the firm's price target on Aemetis to $3 from $2.20 and keeps a Buy rating on the shares. Aemetis announced that the California Air Resources Board has approved provisional pathways under the Low Carbon Fuel Standard for seven dairy digesters built and operated by Aemetis Biogas, which are effective as of January 1, 2025, the analyst tells investors in a research note.
Ascendiant
Edward Woo
Buy
maintain
$19 -> $20
2025-06-06
Reason
Ascendiant
Edward Woo
Price Target
$19 -> $20
2025-06-06
maintain
Buy
Reason
Ascendiant analyst Edward Woo raised the firm's price target on Aemetis to $20 from $19 and keeps a Buy rating on the shares. The company reported weaker Q1 revenue but a positive outlook for 2025, the analyst tells investors in a research note. The firm says Aemetis' large product potential for renewable fuels makes the stock attractive.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AMTX
Unlock Now

People Also Watch